Low levels of resistance have been detected against one of the newest antibiotics, ceftazidime-avibactam, which has been used in the NHS since 2017, the UK Health Security Agency (UKHSA) has warned.

Health officials have warned that bacteria have already become resistant to one of the newest antibiotics on the NHS ...

Even with more restrictive assumptions, the analysis still showed a substantial treatment gap, with only 14.2% of patients ...

aeruginosa infection can often receive adequate MSSA coverage with antipseudomonal agents (with the exception of ceftazidime and aztreonam). The intravenous options for MRSA are generally limited ...

in 0.45% sodium chloride injection SP 0.4 mL/min Ceftazidime Glaxo Wellcome 6039T86 2 g (80 mg/mL) in 0.45% sodium chloride injection SP 0.9 mL/min Ceftriaxone Roche 3829 2 g (66.7 mg/mL ...

and Fortum (ceftazidime). The big challenge is making sure these drugs are used in the best way, to conserve their efficacy as new therapies come through the pipeline, and big part of the Ares ...

The global CRBSI treatment market is on a significant growth trajectory, projected to experience a compound annual growth rate (CAGR) of 5.4% between 2025 and 2035. This growth is being propelled by ...